Background: During the spike of COVID-19 pandemic in Kazakhstan (June-2020), multiple SARS-CoV-2 PCR-test negative pneumonia cases with higher mortality were reported by media. We aimed to study the epidemiologic characteristics of hospitalized PCR-test positive and negative patients with analysis of in-hospital and post-hospital mortality. We also compare the respiratory disease characteristics between 2019 and 2020. Methods: The study population consist of 17,691 (March–July-2020) and 4600 (March–July-2019) hospitalized patients with respiratory diseases (including COVID-19). The incidence rate, case-fatality rate and survival analysis for overall mortality (in-hospital and post-hospital) were assessed. Results: The incidence and m...
ABSTRACT: BACKGROUND: During the COVID 19 pandemic, many patients had respiratory symptoms such as ...
A recently developed pneumonia caused by SARS-CoV-2 bursting in Wuhan, China, has quickly spread acr...
Objectives: To avoid worsening from mild, moderate, and severe diseases and to reduce mortality, it ...
During the spike of COVID-19 pandemic in Kazakhstan (June-2020), multiple SARS-CoV-2 PCR-test negati...
Background: The earliest coronavirus disease-2019 (COVID-19) cases in Central Asia were announced in...
Background: We are communicating the results of investigating statistics on SARS-CoV-2-related pneum...
Background We are communicating the results of investigating statistics on SARS-CoV-2-related pneumo...
Abstract Background The coronavirus induced disease 2019 (COVID-19) pandemic caused by the severe ac...
Background: The characteristics, outcomes, and risk factors for in-hospital death of critically ill ...
International audienceBackground. – Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inf...
Introduction: The first case of COVID-19 infection in Kazakhstan was registered on March 13, 2020. A...
Background The aim of this study was to describe the clinical characteristics and outcome of patient...
Introduction: The new coronavirus named SARS-CoV-2, emerged in Wuhan, China in December 2019 and cau...
Introduction: An unidentified cluster of pneumonia was identified in Wuhan city of China in the last...
BACKGROUND: The 2019 coronavirus disease outbreak (COVID-19) quickly swept the world in just a mont...
ABSTRACT: BACKGROUND: During the COVID 19 pandemic, many patients had respiratory symptoms such as ...
A recently developed pneumonia caused by SARS-CoV-2 bursting in Wuhan, China, has quickly spread acr...
Objectives: To avoid worsening from mild, moderate, and severe diseases and to reduce mortality, it ...
During the spike of COVID-19 pandemic in Kazakhstan (June-2020), multiple SARS-CoV-2 PCR-test negati...
Background: The earliest coronavirus disease-2019 (COVID-19) cases in Central Asia were announced in...
Background: We are communicating the results of investigating statistics on SARS-CoV-2-related pneum...
Background We are communicating the results of investigating statistics on SARS-CoV-2-related pneumo...
Abstract Background The coronavirus induced disease 2019 (COVID-19) pandemic caused by the severe ac...
Background: The characteristics, outcomes, and risk factors for in-hospital death of critically ill ...
International audienceBackground. – Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inf...
Introduction: The first case of COVID-19 infection in Kazakhstan was registered on March 13, 2020. A...
Background The aim of this study was to describe the clinical characteristics and outcome of patient...
Introduction: The new coronavirus named SARS-CoV-2, emerged in Wuhan, China in December 2019 and cau...
Introduction: An unidentified cluster of pneumonia was identified in Wuhan city of China in the last...
BACKGROUND: The 2019 coronavirus disease outbreak (COVID-19) quickly swept the world in just a mont...
ABSTRACT: BACKGROUND: During the COVID 19 pandemic, many patients had respiratory symptoms such as ...
A recently developed pneumonia caused by SARS-CoV-2 bursting in Wuhan, China, has quickly spread acr...
Objectives: To avoid worsening from mild, moderate, and severe diseases and to reduce mortality, it ...